Star and Life Singularity Announce Strategic Partnership to Build Autonomous Healthcare Infrastructure
...we give our clients a practical path to operationalize and scale AI’s impact on patients.”
SUNNYVALE, CA, UNITED STATES, March 5, 2026 /EINPresswire.com/ -- Star, a global technology consultancy, today announced a strategic partnership with Life Singularity, a frontier healthcare AI platform specializing in a proprietary Agentic AI Council and causal digital twins for predictive health. Together, the companies will combine Life Singularity’s “predictive immune system” with Star’s engineering, interoperability, regulatory consulting and product-design capabilities to build autonomous healthcare infrastructure. The goal is to help health systems, payers, healthtech and life‑science organizations embed advanced AI reasoning into real‑world, compliant clinical workflows and products.— Mahesh Naphade
“We fundamentally believe that technology only creates impact when it powers solutions people can actually use,” said Michael Schreibmann, CEO of Star. “We are thrilled to partner with Life Singularity to turn breakthrough AI into everyday care.”
Life Singularity contributes proprietary Agentic AI Council, AI-driven multi-modal risk models, computable phenotypes and causal digital twins built on large-scale clinical, social-determinant and geospatial data, orchestrated by a multi-agent “Predictor–Critic” reasoning architecture. Star contributes data engineering, FHIR-based interoperability, precision interventional user experience and regulatory expertise to turn that AI into deployable, interoperable and compliant solutions used by clinicians, patients and caregivers.
Sanjeev Wadhwa, Founder, President and CEO of Life Singularity, added: “Our vision is to provide a 'Predictive Immune System' for healthcare. Using our proprietary Agentic AI Council and Predictor-Critic multi-agent framework, we simulate thousands of patient trajectories to identify the 'Prime Mover' triggers of the Cardio-Renal-Metabolic cascade. Partnering with Star gives us the enterprise muscle to bring this reasoning into real-world clinical environments safely and at scale.”
“As healthcare organizations increasingly experiment with AI, the real struggle lies in last‑mile deployment,” said Mahesh Naphade, Head of Healthcare & Life Sciences at Star. “By turning Life Singularity’s frontier AI into deployable, interoperable and compliant solutions in real healthcare ecosystems, we give our clients a practical path to operationalize and scale AI’s impact on patients.”
Star and Life Singularity will jointly focus on three primary solution pillars:
1) Orchestrating prevention and outcomes (payers and providers)
Solutions that use Prime‑Mover logic and cardio‑renal‑metabolic digital twins to shift from crisis care to comorbidity compression. They embed these insights into clinical workflows that improve outcomes and lower the total cost of care.
2) Personalized precision intervention at home (healthtech and device OEMs)
Solutions that turn wearables and home devices into a “care companion” that predicts decline and recommends the next best action. They enable safe use in high‑risk populations through personalized dosing, connectivity and SaMD‑grade user experience
3) Digital twinning for regulatory-grade evidence (pharma and medtech)
Solutions that use causal digital twins to identify pre‑disease cohorts, simulate trajectories and refine trial strategies. They generate regulatory‑grade real‑world evidence through validated, ISO 13485‑aligned data and evidence pipelines.
Star has been recognized globally, including with the iF Design Award and UX Design Award for the OYSTA Digital Service, underscoring its ability to deliver intuitive, patient‑centric digital health experiences that meet the highest medical and technical standards.
About Star
Star is a global technology consultancy that helps enterprises bridge strategy and execution through deep industry expertise and an AI‑native delivery engine to design, build and scale digital solutions with lasting business value and end‑user impact. With deep expertise in regulated healthcare technology, including Software as a Medical Device, digital therapeutics, interoperability and connected devices, Star partners with clients to design, build and launch high-impact products and platforms.
About Life Singularity
Life Singularity is a frontier AI company building the "Predictive Immune System for Healthcare," an autonomous AI infrastructure designed to move the industry from reactive monitoring to precision intervention. Leveraging an NVIDIA-native "Physics Engine" and a proprietary Agentic AI Council, the platform performs complex clinical reasoning to identify "Prime Mover" triggers within the Cardio-Renal-Metabolic cascade—anticipating the progression from diabetes to chronic kidney disease and heart failure before clinical events occur. Through its specialized Predictor-Critic multi-agent framework, Life Singularity ensures that its causal digital twins provide deterministic, medical-grade insights for pharmaceutical R&D, global health systems, and digital health ecosystems. As a member of the NVIDIA Inception and Microsoft for Startups programs, Life Singularity is operationalizing a $2.2 trillion shift toward early detection and comorbidity compression.
Cherry Ye
Star
cye@star.global
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
